SUNG WON CHUNG

Clinical Assistant Professor

Asan Medical Center

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sung Won Chung is a Clinical Assistant Professor at Asan Medical Center in South Korea. His research focuses on hepatocellular carcinoma, autoimmune hepatitis, and diabetes-related liver complications, as evidenced by his recent publications. Dr. Chung's work explores the prognostic implications of various treatments and the generalizability of cohort studies in liver disease. He is actively contributing to advancing the understanding of liver-related malignancies and metabolic liver diseases.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

View details

Jonggi Choi

Assistant Professor

Asan Medical Center

SOUTH KOREA

Assistant Professor

Seoul National University Hospital

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

SUNG WON CHUNG

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Synergistic effects of L-arginine and argininosuccinate synthetase 1 in inducing apoptosis in hepatocellular carcinoma

Synergistic Effects of Transarterial Chemoembolization and Lenvatinib on HIF-1α Ubiquitination and Prognosis Improvement in Hepatocellular Carcinoma

Extrahepatic malignancies in metabolic dysfunction‐associated fatty liver disease: A nationwide cohort study

Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study

Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma

The Predictive Value of Time‐Varying Noninvasive Scores on Long‐Term Prognosis of NAFLD in South Korea

Risk of Extrahepatic Malignancies in Patients With Autoimmune Hepatitis: A Nationwide Cohort Study

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma

Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients.

COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B

Association between statin use and the prognosis of hepatocellular carcinoma after resection: a nationwide cohort study

COVID-19 vaccination alters NK cell dynamics and transiently reduces HBsAg titers among patients with chronic hepatitis B

Association of Chronic Hepatitis B Infection and Antiviral Treatment With the Development of the Extrahepatic Malignancies: A Nationwide Cohort Study

Collaborators (10)

Heejoon Jang

Bo Ram Yang

Eun Ju Cho

Jonggi Choi

Sehoon Park

Jeong-Hoon Lee

Moon Haeng Hur

HA IL KIM

Hyunjae Shin

Dong Hyeon Lee

Make your next move.